@article{c354198199b24a3dbd8ee28df4e910ea,
title = "Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study",
keywords = "NATIONWIDE NONMEDICAL SWITCH, RHEUMATOID-ARTHRITIS, DISEASE-ACTIVITY, SELF-EFFICACY, INFLAMMATORY ARTHRITIS, CLINICAL-OUTCOMES, DANBIO REGISTRY, INFLIXIMAB, EXPERIENCE, CT-P13",
author = "Lieke Tweehuysen and Huiskes, {Victor J. B.} and {van den Bemt}, {Bart J. F.} and Vriezekolk, {Johanna E.} and Steven Teerenstra and {van den Hoogen}, {Frank H. J.} and {van den Ende}, {Cornelia H.} and {den Broeder}, {Alfons A.}",
year = "2018",
month = sep,
day = "1",
doi = "10.1002/art.40516",
language = "English",
volume = "70",
pages = "1408--1418",
journal = "Arthritis & Rheumatology",
issn = "2326-5191",
publisher = "Wiley",
number = "9",
}